Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2026-02-04 @ 9:36 AM
Study NCT ID:
NCT05862194
Status:
COMPLETED
Last Update Posted:
2023-08-22
First Post:
2023-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retrospective, External Comparator Study of Lazertinib as the 2nd-Line Treatment in Patients With EGFR Mutation+ NSCLC
Sponsor:
Organization: